ClinicalTrials.gg

Hypera Pharma clinical trials

Also known as Hypermarcas.

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 25 studies whose lead sponsor is Hypera Pharma or one of 2 companies grouped under it. 7 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 5, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Compare Hypera Pharma with Bayer →

Pipeline: 2 programs

Each counted once: 2 with a study Hypera Pharma leads registered in the last two years.

  • Phase 3
  • Phase 4 (approved, new studies)

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Hypera Pharma’s own registered studies; Hypera Pharma’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Hypera Pharma’s studies test, most open studies first — 10 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

6 of Hypera Pharma’s studies under way reach primary completion within a year, 2 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 1N’26
  2. 1D
  3. 1J’27
  4. F
  5. 1M
  6. A
  7. M
  8. 2J
  9. J
  10. A
  11. S
  12. O
  13. N

Add all 6 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 18, 2026.

All 25 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now728%Recruiting 6 · Not yet recruiting 1
  • Completed624%
  • Status unknown or other1248%

Phase

  • Phase 314
  • Phase 41

Where

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 1126

By the year each study started; 1 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Hypera Pharma.

  • Brainfarma Industria Química e Farmacêutica S/A
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    15 studies →
  • Mantecorp Industria Quimica e Farmaceutica Ltd.
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    10 studies →

Studies

Recruiting first, then most recently updated. Showing 25 of 25.